Atridia Pty Ltd.
Clinical trials sponsored by Atridia Pty Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New psoriasis drug candidate SHR-1139 begins first human safety check Results expected Sep 2026 (estimated)
- New pill for chronic hives enters first human tests Results expected Oct 2026 (estimated)
- New pill HRS-5041 tested in men with Tough-to-Treat prostate cancer Results expected Dec 2026 (estimated)
- New obesity drug HRS-5817 enters human safety testing Results expected Jan 2027 (estimated)
- New hope for breast cancer: experimental combo enters human trials Results expected Apr 2027 (estimated)